Pfizer: US FDA approves rare heart disease drug
(CercleFinance.com) - The US Food and Drug Administration has approved Pfizer's drug to treat a rare heart disease.
The FDA has approved its treatment of transthyretin amyloid cardiomyopathy, a life-threatening disease characterized by the buildup of abnormal deposits of misfolded protein in the heart.
To date, there are no approved medicines available to treat this disease, which affects approximately 100,000 people in the US.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The FDA has approved its treatment of transthyretin amyloid cardiomyopathy, a life-threatening disease characterized by the buildup of abnormal deposits of misfolded protein in the heart.
To date, there are no approved medicines available to treat this disease, which affects approximately 100,000 people in the US.
Copyright (c) 2019 CercleFinance.com. All rights reserved.